News Release

Study reveals possible link between autism and oxytocin gene via non-DNA sequence mutation

Peer-Reviewed Publication

BMC (BioMed Central)

A new study indicates a link between autism and alterations to the oxytocin receptor, OXTR, caused by inherited alterations that do not involve DNA sequence mutation. The study, published in the open access journal BMC Medicine, identified the non-DNA change in 'OXTR' via an autistic child and his mother, who potentially has obsessive-compulsive disorder.

Dr Simon Gregory headed up a team from the US, UK and Italy, who analysed the DNA of 119 people with autism and 54 neurotypical individuals. He said, "As many as 1 in 150 children in the US are born with a form of autism. We have shown that the non-DNA sequence mutation in the gene responsible for the oxytocin receptor is altered in both peripheral blood cells and the temporal cortex of the brain".

The oxytocin pathway has many known effects, from facilitating breast-feeding to childbirth and social interaction. This discovery shows that it also plays a major role in human development.

Dr Gregory concludes, "This study provides additional evidence for the role of oxytocin and its receptor in the development of autism. It also shows that autism will be caused by a number of different factors, not just those involving the sequence of our genomes".

###

Notes to Editors:

1. Genomic and epigenetic evidence for oxytocin receptor deficiency in autism
Simon G Gregory, Jessica J Connelly, Aaron J Towers, Jessica Johnson, Dhani Biscocho, Christina A Markunas, Carla Lintas, Ruth K Abramson, Harry H Wright, Peter Ellis, Cordelia F Langford, Gordon Worley, G Robert Delong, Susan K Murphy, Michael L Cuccaro, Antonello Persico and Margaret A Pericak-Vance
BMC Medicine (in press)

During embargo, article available here: http://www.biomedcentral.com/imedia/1296347307305503_article.pdf?random=168632

After the embargo, article available at journal website: http://www.biomedcentral.com/bmcmed/

Please name the journal in any story you write. If you are writing for the web, please link to the article. All articles are available free of charge, according to BioMed Central's open access policy.

Article citation and URL available on request at press@biomedcentral.com on the day of publication

2. BMC Medicine - the flagship medical journal of the BMC series - publishes original research articles, commentaries and reviews in all areas of medical science and clinical practice. To be appropriate for BMC Medicine, articles need to be of outstanding quality, broad interest and special importance. BMC Medicine (ISSN 1741-7015) is indexed/tracked/covered by PubMed, MEDLINE, BIOSIS, CAS, Scopus, EMBASE, Current Contents, Thomson Reuters (ISI) and Google Scholar.

3. BioMed Central (http://www.biomedcentral.com/) is an STM (Science, Technology and Medicine) publisher which has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.